Newark, DE, United States of America

Vijayarajan Devannah

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Prelude Therapeutics Incorporated. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vijayarajan Devannah. Retrieved from https://idiyas.com/inventor/vijayarajan-devannah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vijayarajan Devannah: Pharmaceutical Patent Inventor.

Introduction

Vijayarajan Devannah is an inventor based in Newark, Delaware, whose patent work concerns pharmaceutical compounds and their potential uses. The supplied information identifies him as an inventor on one patent and as an employee of Prelude Therapeutics Incorporated.

Latest Patents

Devannah is associated with the patent “BRM Targeting Compounds and Associated Methods of Use.” The disclosure describes compounds of Formula I, pharmaceutical compositions containing those compounds, and methods for their preparation and use. The supplied data lists 1 patent and does not specify its filing or grant date.

Career Highlights

Devannah’s listed patent reflects work in pharmaceutical research and development, particularly the disclosure of compounds and related methods. His company, Prelude Therapeutics Incorporated, is identified as his professional affiliation.

Collaborations

The supplied information names Corey Howard Basch and Song Mei as Devannah’s coworkers. Their connection to the patent or to specific research activities is not detailed in the provided data.

Conclusion

Vijayarajan Devannah’s documented patent contribution centers on BRM-targeting compounds and associated pharmaceutical compositions and methods, reflecting his connection to innovation at Prelude Therapeutics Incorporated.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…